/PRNewswire/ Holland & Knight announced the expansion of the firm s Healthcare & Life Sciences Industry Group, a cross-disciplinary team of more than 400.
Philippines: Digital Healthcare Guide globalcompliancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalcompliancenews.com Daily Mail and Mail on Sunday newspapers.
By
Holland & Knight LLP issued the following announcement on Mar. 8.
Healthcare attorney Jennifer Rangel has joined Holland & Knight s Austin, Texas, office as a partner. She focuses on regulatory, transactional and administrative health law for healthcare providers, healthcare industry companies, payors, health plans and managed care organizations. Ms. Rangel was formerly a partner with Locke Lord.
Ms. Rangel joins nearly a year after Holland & Knight announced the expansion of its national healthcare practice into Texas with the hiring of litigators Eliot Burris in Dallas and Samuel Louis and Justo Mendez in Houston. We are thrilled to have someone of Jennifer s caliber helping to build our healthcare capabilities in Texas, said Jeffrey Mittleman, co-leader of the firm s Healthcare & Life Sciences Industry Group. Strategically, Jennifer s experience and local knowledge mirrors the type of healthcare work that Holland & Knight does in states such as Florida, Georgia, M
To embed, copy and paste the code into your website or blog:
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement regimes.
In this episode of our Connected With Latham podcast series, Washington D.C. See more +
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement